Trotana Therapeutics develops novel oral anti-inflammatory medicines, focusing on addressing significant unmet needs in chronic inflammatory diseases
Trotana Therapeutics develops novel oral anti-inflammatory medicines, focusing on addressing significant unmet needs in chronic inflammatory diseases. The company leverages advanced biological insights, likely rooted in RNA biology and computational methods, to discover and optimize small molecule therapeutics.